相关实验视频
Updated: Jun 29, 2025

06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
35.2K
在癌症初步研究中的炎症因素和基因斯坦补充剂
Karolina Banyś1, Małgorzata Jelińska1, Małgorzata Wrzosek2
1Department of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Poland, Banacha 1, 02-097 Warsaw, Poland.
Current issues in molecular biology
|March 27, 2024
概括
多种形式的基因斯坦补充剂在老鼠中加剧了瘤过程. 然而,它降低了特定的eicosanoids,同时增加了矩阵金属蛋白酶-9 (MMP-9) 水平和基因表达,影响了癌症的发展.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 基因斯坦是一种大豆异黄,已显示出潜在的抗癌性质.
- 了解基尼斯坦的剂量依赖性和大小依赖性影响对于其治疗应用至关重要.
- 在瘤进展中,eicosanoids和促炎性细胞因子的作用需要进一步阐明.
研究的目的:
- 评估纳米,微和宏基因斯坦对大鼠DMBA诱导瘤的影响.
- 调查潜在的机制,包括对eicosanoids,细胞因子和MMP-9的影响.
- 评估基因斯坦对瘤强度和相关生物标志物的影响.
主要方法:
- 雌性Sprague Dawley大鼠 (n=32) 被分为四组:对照组和补充Genistein的 (宏观,微观,纳米).
- 乳腺腺癌被诱导使用7,12-二甲基-1,2-[a]炭烯 (DMBA).
- 使用液体染色学,免疫酶分析和qRT-PCR来量化埃可索诺因,细胞因子 (IL-1,IL-6) 和MMP-9.
主要成果:
- 基因斯坦补充剂,无论形式如何,都加剧了瘤过程.
- 补充组显示12-HEPE,HODE和12-HETE的水平明显较低.
- 纳米,微和宏基因斯坦增加了MMP-9水平,在宏基因组中显著增加了MMP-9基因表达.
结论:
- 在所有测试的形式中,饮食中的基因斯坦在老鼠中加剧了瘤过程.
- 基尼斯补充剂改变了eicosanoid配置文件和上调的MMP-9,这表明在癌症进展中起着复杂的作用.
- 这些发现凸显了在癌症研究和治疗中需要仔细考虑基因斯坦的剂量和形式的必要性.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Activation of Integrins
3.4K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.4K

